Epigenetic silencing of miR-137 induces resistance to bicalutamide by targeting TRIM24 in prostate cancer cells

Prostate cancer is an important hormone-dependent cancer affecting men. In the initial stages, prostate cancer is often treated using hormone therapy, including bicalutamide. Despite the initial effectiveness of this therapy, the tumor eventually acquires resistance, resulting in recurrence of castr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Transl Res
Autors principals: Guan, Yonghui, Guan, Xiaoyue, An, Hengqing, Baihetiya, Azhati, Wang, Wenguang, Shao, Weimin, Yang, Haiou, Wang, Yujie
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556665/
https://ncbi.nlm.nih.gov/pubmed/31217891
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars